Sector: Pharmaceuticals & Biotechnology
|Large Cap
Wockhardt Ltd.
₹1,577
Invest in WOCKPHARMA with up to 2.22x margin.
Trade with MTF₹1569.00
₹1614.70
₹1086.70
₹1868.80
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 516 | 430 | 380 | 413 | 355 |
| Operating Expense | 355 | 317 | 267 | 282 | 249 |
| Operating Profit | 161 | 113 | 113 | 131 | 106 |
| Depreciation | 43 | 52 | 45 | 46 | 40 |
| Interest | 41 | 50 | 44 | 41 | 40 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 167 | 28 | 54 | 69 | 40 |
₹1577.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 |
| FII | 6.5 | 6.8 | 7.3 | 7.1 | 7 | 7.1 |
| DII | 9.9 | 10.6 | 11 | 11 | 10.6 | 11 |
| Public | 34.5 | 33.5 | 32.6 | 32.8 | 33.4 | 32.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4.44 L | 15.16 L | 29.31% |
| Week | 4.27 L | 13.46 L | 31.75% |
| 1 Month | 5.54 L | 30.68 L | 18.06% |
| 6 Month | 3.22 L | 13.99 L | 23.05% |
Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Growth Stars: Strongest Annual EPS Performers
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 17 Nov, 2016 | 10 | INTERIM | 19 Nov, 2016 | Equity Share |
| 13 Nov, 2014 | 20 | INTERIM | 15 Nov, 2014 | Equity Share |
| 17 Feb, 2014 | 5 | INTERIM | 19 Feb, 2014 | Equity Share |
| 07 Nov, 2013 | 5 | INTERIM | 08 Nov, 2013 | Equity Share |
| 22 Aug, 2013 | 5 | FINAL | Equity Share | |
| 17 Apr, 2008 | 2.5 | FINAL | Equity Share | |
| 26 Oct, 2007 | 8.75 | INTERIM | 29 Oct, 2007 | Equity Share |
| 22 Mar, 2007 | 5 | FINAL | 23 Mar, 2007 | Equity Share |
| 21 Jun, 2006 | 5 | FINAL | Equity Share | |
| 12 Apr, 2005 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,106 | ₹1,824.80 | ₹1,715 | ₹2,479.40 | ₹175.01 | ₹2,953.20 |
| % Change | -0.70% | -0.53% | 0.08% | -0.00% | -0.35% | 0.07% |
| Revenue TTM (₹ Cr) | ₹2,192.49 | ₹1,421.59 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 | ₹1,339.37 |
| Net Profit TTM (₹ Cr) | ₹348.91 | ₹-73.80 | ₹924.36 | ₹1,912.93 | ₹-325.93 | ₹356.26 |
| PE TTM | 69.40 | -290.10 | 35.60 | 55.80 | -71.90 | 66.20 |
| 1 Year Return | 52.37 | 14.63 | 61.15 | 0.77 | -14.16 | 142.29 |
| ROCE | 18.38 | 0.59 | 25.65 | 13.27 | 2.29 | 27.72 |
Gland Pharma Ltd.
₹ 2334.00
+0.00%
Laurus Labs Ltd.
₹ 1343.50
+0.00%
Alkem Laboratories Ltd.
₹ 5414.00
+0.18%
Biocon Ltd.
₹ 429.90
-0.08%
Divi's Laboratories Ltd.
₹ 6900.00
+0.19%
Ajanta Pharma Ltd.
₹ 3118.00
+0.34%
Zydus Lifesciences Ltd.
₹ 1038.60
-0.03%
Glenmark Pharmaceuticals Ltd.
₹ 2259.10
+0.00%
Aurobindo Pharma Ltd.
₹ 1468.00
+0.31%
Natco Pharma Ltd.
₹ 1170.00
+0.03%
Sun Pharmaceutical Industries Ltd.
₹ 1844.60
+0.00%
Neuland Laboratories Ltd.
₹ 16681.00
-0.07%
Ipca Laboratories Ltd.
₹ 1603.50
+0.09%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2190.30
-0.10%
AstraZeneca Pharma India Ltd.
₹ 8577.00
-0.12%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2313.90
+0.30%
Pfizer Ltd.
₹ 4659.30
-0.25%
Abbott India Ltd.
₹ 27855.00
+0.09%
Torrent Pharmaceuticals Ltd.
₹ 4497.00
+0.24%
Lupin Ltd.
₹ 2270.70
-0.49%
Dr. Reddy's Laboratories Ltd.
₹ 1310.00
+0.21%
Cipla Ltd.
₹ 1399.20
+0.00%
By signing up I certify terms, conditions & privacy policy